Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study (Q73190388)
Jump to navigation
Jump to search
scientific article published on 01 November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study |
scientific article published on 01 November 2000 |
Statements
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study (English)
J Bonneterre
B Thürlimann
J F Robertson
L Mauriac
P Koralewski
A Webster
M Steinberg
1 November 2000